register free | resend password

Pressemitteilungen zu dem Thema pharma


Unterkategorien

PresseMitteilungen zu dem Schlagwort pharma


PAREXEL and CHA Medical Group Partner to Enhance Early Phase Clinical Research in Korea

Collaboration combines best-in-class offerings from CHA and PAREXEL to enhance early phase clinical trials in growing hub for drug development BOSTON, March 13, 2018 - PAREXEL International Corporation, the world''s leading innovator of biopharmaceutical services, today announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea. The collaboration is designed to provide biopharmaceutical companies with comprehensive services that leverage PA ...


13.03.2018

G&L Scientific announces the appointment of Jessica Kokosinski as Vice President, Regulatory Affairs

Warren, NJ, 6 March, 2018 - G&L Scientific Inc, a leading provider of Clinical Research and Regulatory Affairs consulting to the healthcare industry, is delighted to announce the appointment of Jessica Kokosinski as Vice President, Regulatory Affairs. Jessica has successfully set up and led numerous long-term, large-scale regulatory engagements and teams across the entire product lifecycle, from clinical development to new product filings and post-approval activities for pharmaceutical, bio ...


06.03.2018

PAREXEL Appoints Jamie Macdonald as Chief Executive Officer

BOSTON, March 6, 2018 - PAREXEL International Corporation, the world''s leading innovator of biopharmaceutical services, today announced the appointment of Jamie Macdonald as Chief Executive Officer (CEO) effective March 15, 2018. Josef von Rickenbach, who co-founded the Company, will retire from his daily CEO duties and continue as Chairman of the Board. "It is a tremendous honor for me to join PAREXEL," said Jamie Macdonald. "As a trail blazer in the biopharmaceutic ...


06.03.2018

Alfa Laval´s UltraPure Pumps - Efficient, Sustainable and Consumer Safe

Alfa Laval UltraPure pumps are specifically designed for the toughest, most demanding pharmaceutical applications. From high-value, high-risk productions, where every second counts, to reliability and repeatability process-driven productions - whatever your challenge is, there is an UltraPure solution to meet your needs. Consumer Safety Alfa Laval UltraPure pumps feature a high level of attention to hygiene and repeatability to reduce the risk of contamination. The downloadable Q-doc documenta ...


21.02.2018

Alfa Laval´s UltraPure Pumps - Efficient, Sustainable and Consumer Safe

Consumer Safety Alfa Laval UltraPure pumps feature a high level of attention to hygiene and repeatability to reduce the risk of contamination. The downloadable Q-doc documentation, based on GDP (Good Documentation Practice), provides full details of the product. It simplifies qualification, validation and change control to assure consumer safety. Proven reliability All pumps use robust designs that are time-tested and proven in the pharmaceutical industry. Every UltraPure pump includes full docu ...


20.02.2018

PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development

BOSTON, February 12, 2018 - PAREXEL International Corporation, the world''s leading innovator of biopharmaceutical services, today launched its Biological Sample Lifecycle Management service, enabling optimal use of human biological samples. The new service enables biopharmaceutical clients to more efficiently manage their often irreplaceable patient biological sample assets from informed consent and collection at site, through in-study laboratory analysis, data generation and future u ...


12.02.2018

NEW! LogTag® USB Data Logger Series!

The growing LogTag effective and reliable models with integrated USB port. The two LogTag They are complemented by the reusable USB loggers UTRIX-16 and UTRID-16. These two data loggers are ideal for all applications where a logger can easily be recovered and reused several times. All USB models can be plugged directly into a PC In addition, the UTRID-16 also impresses with its six level multi-alarm display. LogTag data loggers are praised worldwide for their reliability and ease of use, exce ...


30.01.2018

Global Pharmacy Automation Market Research Size, Shares, Strategies, Trend, Growth And Forecasts Worldwide 2022 - Credence Research

According to a new market report published by Credence Research Inco rising drug prices and reducing drug reimbursements. Advanced pharmacy automation solutions not only reduce medication errors but also help in inventory management. Automation also reduces number of staff required to manage and control pharmacy operations which reduces cost per employee for healthcare providers. All these benefits are expected spur the demand for pharmacy automation solutions through the forecast period 2016 - ...


16.01.2018

Buy your medicines from this high rated Canadian online pharmacy

Avalon Pharmacy has emerged as the leader in the Canadian online pharmacy business. Emerging among the first online Canadian pharmacies it has taken the market by storm. Offering some of the cheapest options for people it has quickly gained prominence among the customers and the word about is has soon spread all over Canada. As of today this pharmacy has little to no competition in the online market and is proving to be the clear favourite due to its high customer support services standards and ...


16.01.2018

Pharmacy Automation Market Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

The for pharmacy automation solutions is growing steadily with rising pressure to reduce medication errors and stringent government regulations across the world. In addition, rising awareness about the benefits of pharmacy automation solutions is also driving the demand these solutions with rising number of patient visits per day. This represents a positive outlook for solutions providers across the value chain of pharmacy automation industry. This report includes in-depth information on factor ...


28.12.2017

Worldwide Pharmaceutical Packaging Market Share, Size, Growth, Trends, Industry Analysis and Forecast 2025 By Credence Research

According to the latest report published by Credence Research, Inc. Browse the full Market Insights Global pharmaceutical packaging market comprises study of all the materials used for packaging of the pharmaceuticals. The global market includes the packaging carried out by the manufacturing companies as well as drugs packed on the contract basis. Numerous materials are utilized for the packaging of the drugs including plastics, polymers, paper, glass, aluminum foil. Due to the increasing glo ...


19.12.2017

PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry

Cloud Platform Built on Microsoft Azure Delivers PAREXEL BOSTON, December 12, 2017 Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL Perceptive Cloud is designed to respond to the need within healthcare to deliver cost-effective innovation while trusting that sensitive information will stay secure across global environments. Introducing Perceptive Cloud represents the first milestone of the enterprise al ...


12.12.2017

Europe''s Leading Pre-Filled Syringes Summit to Showcase New Innovations from Leading Manufacturing and Pharmaceutical Experts

Aimed at capturing emerging trends in PFS injector technology, regulation and patient centric drug delivery, SMi Group’s flagship conference and exhibition on Pre-Filled Syringes will gather a global audience of over 100 senior PFS experts and big pharma when it returns to Central London on 17th and 18th January 2018 for its 10th annual show. “We are delighted to chair this forum which has been drafted with great care to allow for the very best discussions and engagement on crucial topics for o ...


27.11.2017

Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China Pharmaceutical Partner

LAVAL, QUEBEC -- (Marketwired) -- 11/20/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that the company recently entered into a non-binding term sheet with a leading China-based pharmaceutical company. Completion of the transaction is subject to further negotiation ...


20.11.2017

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

OTTAWA, ONTARIO -- (Marketwired) -- 11/16/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps™, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. ("Aphria") under Access to Cannabis for Medical Purposes Regulations (ACMPR).Based on the most recent A ...


16.11.2017

PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry

New Appointments Enhance PAREXEL’s Leadership and Expertise in Bringing Commercially Viable, Reimbursable Products to Market BOSTON, November 15, 2017 - PAREXEL, a leading global biopharmaceutical services provider, today announced the appointment of three former senior regulatory consulting executives from the U.S. Food and Drug Administration (FDA) and Oncology industry positions. The new hires are part of PAREXEL’s Global Integrated Product Development and Compliance team and will be focused ...


15.11.2017

Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

VANCOUVER, BC -- (Marketwired) -- 11/09/17 -- . (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce the signing of a Binding Letter of Intent with Thrudermic, LLC, a privately held North Carolina company, to acquire worldwide rights to Thrudermic''s Transdermal Nanotechnology for the development and commercialization of topical cannabinoids. In addition, Dr. Joseph Borovsky and Dr. Leonid Lurya, Thrudermic''s Chief Executive Officer and Chief ...


09.11.2017

Tetra Bio-Pharma Concludes its First Sale of Rx Princeps(TM) Inhalation Device

OTTAWA, ONTARIO -- (Marketwired) -- 11/09/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced its first sale of its Rx Princeps™ inhalation device. The sale of this inhalation device is the first step towards the sale of Rx Princeps™."I am happy to announce the first batch order of our medical cannabis inhalation devices. This is the first step in g ...


09.11.2017

Pharmaceutical Companies Poised to Build Infrastructure to Accommodate Real World Evidence, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 11/08/17 -- Real world evidence is poised to play a growing role in drug development during the next three years, but the availability and cost of acquiring data remain key challenges, according to a recently completed study conducted by the .Large pharmaceutical, biotechnology, and contract research organizations plan to increase internal staff dedicated to collection and analysis of real world data by 25% between now and 2020, according to a survey conducted by ...


08.11.2017

Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals

LOS ANGELES, CA -- (Marketwired) -- 11/01/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced completion of pivotal manufacturing agreements that enable the production of clinical-grade cannabinoid pharmaceuticals at its R&D facili ...


01.11.2017

Pre-Filled Syringes Europe Attendee List Released

Preliminary attendee list released featuring MHRA, Boehringer Ingelheim, Janssen, Amgen, Merck and Novartis, 3P Innovation, Intertek, Nemera, Terumo, Worrell and Zeon (LONDON, UK) SMi’s Pre-Filled Syringes Europe Conference & Exhibition will take place on 17-18 January at the Copthorne Tara Hotel in London, UK. SMi’s 2017 global portfolio of events on Pre-Filled Syringes secured an audience of over 300 senior drug delivery and medical device experts. Growing year on year, the flagship 10 ...


01.11.2017

Sermonix Pharmaceuticals Announces Recent Closure of $4.2 Million Seed Preferred Equity Bridge to Fund Operations, Prepare for Phase II Breast Cancer Study

COLUMBUS, OH -- (Marketwired) -- 10/31/17 -- Sermonix Pharmaceuticals LLC, a privately held biotechnology company focused on the development and commercialization of female-specific oncology products, today announced its recent completion of a $4.2 million Seed Preferred Equity Bridge financing round to fund ongoing operations and prepare for entry of investigational drug lasofoxifene into a Phase II clinical trial in Estrogen Receptor Positive (ER+) Metastatic Breast Cancer.Lasofoxifene, a new ...


31.10.2017

National Certification Commission for Acupuncture and Oriental Medicine(R) Applauds the National Association of Attorneys General Initiative in Fight Against Opioid Crisis

JACKSONVILLE, FL -- (Marketwired) -- 10/30/17 -- The (NCCAOM)®, which has long stressed the importance of non-drug approaches to chronic pain, commends the National Association of Attorneys General (NAAG) for its September 18th encouraging healthcare providers to prioritize non-opioid pain management options over opioid prescriptions for the treatment of chronic pain. The letter addresses the necessity for doctors to explore, prescribe and refer patients for effective non-drug treatments such ...


30.10.2017

Hemogenyx Pharmaceuticals Plc ("Hemogenyx" or the "Company"): LakePharma appointed as Service Provider for lead drug development

LONDON, UNITED KINGDOM -- (Marketwired) -- 10/30/17 -- Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment of blood diseases, announced today it has chosen LakePharma, Inc. as its service provider for the development and manufacturing of Hemogenyx''s lead product, CDX bi-specific antibodies. The company believes that CDX bi-specific antibodies could replace tradi ...


30.10.2017

Tetra Bio-Pharma Goes After the Cannabis Oil Medical Market and Launches a Phase 4 Trial with Cannabis Oils in Partnership with Santé Cannabis

OTTAWA, ONTARIO -- (Marketwired) -- 10/26/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced the launch of a medical cannabis oil program as it targets penetrating the lucrative cannabis oil market and strengthens its plans to generate revenues from the medical cannabis market.Last year Tetra launched several drug development programs to commercialize c ...


26.10.2017

Easton Pharmaceuticals Announces Final Payment Completing $1.3 Million JV Agreement With Alliance Group For a 50% Property Ownership Interest and Various Businesses Including The Cultivation of Medical / Recreational Marijuana For National Canadian Market

TORONTO, ON -- (Marketwired) -- 10/20/17 -- Easton Pharmaceuticals, Inc. (OTC: EAPH) is pleased to announce its final payment which completes its $1.3 Million CDN JV agreement with Canadian based 1124123 Ontario Limited (o/a - Alliance Group) towards a 50% property ownership interest and various businesses including the cultivation of medical / recreational marijuana for national Canadian market.Easton has advanced its final payment, completing a total payment of $1.3 Million CDN to 1124123 Ont ...


20.10.2017

Helix BioPharma Corp. Closes Private Placement

RICHMOND HILL, ONTARIO -- (Marketwired) -- 10/19/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for gross proceeds of approximately CAD3,909,600.The terms of the placement are for the purchase of units at $1.20 per unit. Each unit is comprised of one common share and one c ...


19.10.2017

Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

VANCOUVER, BC -- (Marketwired) -- 10/19/17 -- . (OTCQB: PVOTF) ("Pivot" or the "Company"), an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals, today announces the execution of a Binding Letter of Intent to acquire Absorbent Concepts Inc. ("ACI Foods" or "ACI"). Based in Abbotsford, British Columbia, ACI processes, packages and distributes gluten-free, organic hemp nutrit ...


19.10.2017

Tetra Bio-Pharma Hires Medical Science Liaison to Promote Rx Princeps(TM) and Presents its New Corporate Image

OTTAWA, ONTARIO -- (Marketwired) -- 10/19/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced the hiring of Dr. Vincent Jourdain, Ph. D. as medical science liaison (MSL).Dr. Jourdain will be responsible for the medical information of Rx Princeps™ and will be educating the medical community about the benefits of this controlled and standardized blend of m ...


19.10.2017

Vitality Biopharma Announces Positive Results for Multiple Cannabinoid Drug Formulations in Treatment of IBD

LOS ANGELES, CA -- (Marketwired) -- 10/19/17 -- (OTCQB: VBIO) ("Vitality" or the "Company"), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced additional positive preclinical efficacy results for the treatment of colitis.Vitality Biopharma has developed a new class of cannabinoid prodrugs, known as cannabosides, wh ...


19.10.2017

Tetra Bio-Pharma Signs Agreement with Partner Aphria to Start Promoting Rx Princeps(TM), its Medical Cannabis Blend, under ACMPR

OTTAWA, ONTARIO -- (Marketwired) -- 10/18/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that it will start promoting a co-developed medical cannabis blend product under Access to Cannabis for Medical Purposes Regulations (ACMPR). Tetra has signed a distribution agreement with its trusted partner Aphria to sell Rx Princeps™, its unique blend of drie ...


18.10.2017

Vitality Biopharma Announces Publication of International PCT Patent Filing for Cannabinoid Pharmaceuticals

LOS ANGELES, CA -- (Marketwired) -- 10/16/17 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the publication of an international PCT patent application that covers a new class of cannabinoid pharmaceuticals.The publication of the international patent filing is the fi ...


16.10.2017

Tetra Bio-Pharma Continues Forward into the Veterinary Ophthalmology Market by Entering into an Agreement with Drs. Cullen and Webb

OTTAWA, ONTARIO -- (Marketwired) -- 10/13/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced the addition of two members to its clinical advisory board for the veterinary market - Dr. Cheryl Cullen, an American Board-certified Veterinary Ophthalmologist, and Dr. Webb, an American Board of Veterinary Ophthalmology (ABVO) Resident.Drs. Cullen and Webb hav ...


13.10.2017

Easton Pharmaceuticals & JV Partner Alliance Group Announces It Has Cleared Final Hurdles Toward Allowing For The Cultivation of Medical / Recreational Marijuana For National Canadian Market

TORONTO, ON -- (Marketwired) -- 10/10/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced closed agreement with Canadian based -- 1124123 Ontario Limited (o/a - Alliance Group) -- that its legal team has notified Easton / Alliance Group that it has cleared all exemption hurdles allowing for the Cultivation of Medical / Recreational Marijuana for the country of Canada.Easton''s JV partner, 1124123 Ontario Limited (o/a - Alli ...


10.10.2017

Tetra Bio-Pharma Selected to Present at Prestigious BIO Investor Forum In San Francisco October 17-18

OTTAWA, ONTARIO -- (Marketwired) -- 10/04/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug discovery, today announced that it has been selected, among a large group of candidates, to present at the prestigious BIO Investor Forum to be held in San Francisco October 17-18th at the Westin St. Francis Hotel. Robert (Bob) Bechard, Vice-President, Finance and Business Development of Tetra will prese ...


04.10.2017

Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough

LOS ANGELES, CA -- (Marketwired) -- 10/04/17 -- (OTCQB: VBIO) ("Vitality Biopharma", "Vitality", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the achievement of a biosynthesis breakthrough.Vitality has developed a proprietary biosynthesis technology that can modify cannabinoids in o ...


04.10.2017

Jacobson Pharma Completes Issue of HK$500 Million of Convertible Notes to Dragons 615 Limited and HH InRe JP, Ltd.

HONG KONG, CHINA -- (Marketwired) -- 10/03/17 -- (HKSE: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce the completion of issue of the Convertible Notes in a principal amount of HK$500 million to two subscribers namely, Dragons 615 Limited ("Dragons"), a wholly-owned limited liability company of DCP China Credit Fund I, L.P. ("DCP Fund") and HH InRe JP, Ltd. (&quo ...


03.10.2017

PharmaSeek Offers Solution to Slow Payments in the Clinical Research Industry

MADISON, WI -- (Marketwired) -- 09/29/17 -- PharmaSeek, an Investigative Site Network, has launched a new service aimed at eliminating the burden of slow payments for clinical research sites. This service, called PS Pays, is unique to the industry and allows sites to get paid for their work in as little as 72 business hours, instead of waiting for sponsor payments which can take up to 150 days.PharmaSeek, who has partnered clinical research sites with sponsors and CROs for over 20 years, launch ...


29.09.2017

Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum

NEW YORK, NY -- (Marketwired) -- 09/29/17 -- Rising India''s (OTC: RSII) ., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces today that it has launched TSW Topicals (), a range of over-the-counter, topical pain relief products using an innovative blend of clinically proven organic ingredients such as menthol, curcumin, ginger and capsaicin to reduce inflammation and e ...


29.09.2017

Canopy Growth and Skinvisible Sign Definitive Agreement to Bring New Products to Market

SMITH FALLS, ON and LAS VEGAS, NV -- (Marketwired) -- 09/28/17 -- Canopy Growth Corporation ("Canopy Growth" or the "Company") and Skinvisible Pharmaceuticals, Inc. ("Skinvisible") (OTCQB: SKVI), a research and development company with a patented drug delivery system, today announce they have signed a definitive license agreement for Skinvisible''s patented topical formulations. Per the agreement, Canopy Growth is exclusively licensed to distribute Skinvi ...


28.09.2017

Tetra Engages in Innovative Air Analysis and Development of Specific Air Cleaning Devices with AES Environment for the Commercialization of PPP001 and for Marijuana Consumer Market

OTTAWA, ONTARIO -- (Marketwired) -- 09/28/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced that it has signed a letter of intent (LOI) with AES Environment Group to develop and commercialize specific products ensuring the safety of caregivers for patients who will use PPP001 or medical cannabis.AES Environment has expertise in in situ air testing analysis of all kinds of contaminants and development of high level air c ...


28.09.2017

Vitality Biopharma Receives Updated SeeThruEquity Price Target of $2.40

LOS ANGELES, CA -- (Marketwired) -- 09/27/17 -- (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to advise that SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, ...


27.09.2017

Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

VANCOUVER, BC -- (Marketwired) -- 09/25/17 -- . (OTCQB: PVOTF) (Pivot or the Company) and its medical cannabis product division, Pivot Green Stream Health Solutions, today announce the signing of a Definitive Agreement with Solmic Research GmbH (Germany) in which Pivot will acquire worldwide rights to Solmic Solubilisation Technology for the development and commercialization of cannabinoid-containing natural extracts. Solmic''s proprietary technology provides significantly higher bioa ...


25.09.2017

Cocrystal Pharma to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference in New York

ATLANTA, GA and BOTHELL, WA -- (Marketwired) -- 09/22/17 -- Cocrystal Pharma, Inc. (OTCQB: COCP) today announced that Dr. Gary Wilcox and James Martin will be presenting a company overview at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 8:35am in the InterContinental New York Barclay Hotel.Cocrystal is a pharmaceutical company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. Cocrystal ...


22.09.2017

Protext Pharma Announces South Africa''s Reclassification of Cannabis as a Schedule 4 Substance

BOCA RATON, FL -- (Marketwired) -- 09/20/17 -- Protext Pharma, Inc. (PINKSHEETS: TXTM) ("Protext" or "the Company"), a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated with highly-bioavailable plant extracts, today announced that the government of South Africa published recommended amendments to the Medical Innovation Bill that would change the status of cannabis products that do not have psychoactive properties from a Sche ...


20.09.2017

Tetra Bio-Pharma to engage in co-development and distribution partnership with major healthcare specialty distributor

OTTAWA, ONTARIO -- (Marketwired) -- 09/20/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced that it has signed a letter of intent (LOI) with a major player of the healthcare specialty industry.This privately-owned partner, which asked to remain unnamed for the time being, has a pan-Canadian distribution network that reaches up to 7000 specialized healthcare professionals. Through their distribution channel, they have ac ...


20.09.2017

REMINDER - Optymyze to Highlight Best Practices for Leveraging Sales Data at PharmaForce 2017

CHESTER, PA -- (Marketwired) -- 09/18/17 --, a worldwide provider of enterprise cloud applications and services for improving sales and channel performanceWill present a keynote, "Approaching Compensation and Information to Sales Ops," during .Monday, September 18 - Wednesday, September 20, 2017"Approaching Compensation and Information to Sales Ops" is scheduled for Tuesday, September 19 at 3:00 p.m. CDT.Hilton Austin 500 East 4th Street Austin, TexasCollecting data is one th ...


18.09.2017

Protext Pharma to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes

BOCA RATON, FL -- (Marketwired) -- 09/13/17 -- Protext Pharma, Inc. (OTC PINK: TXTM) ("Protext" or "the Company"), a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated with highly-bioavailable plant extracts, today announced that, following extensive investigations with scientists at a leading United States diabetic research institute, the company is modifying its forthcoming diabetes study protocols. The studies will focus o ...


13.09.2017

Optymyze to Highlight Best Practices for Leveraging Sales Data at PharmaForce 2017

CHESTER, PA -- (Marketwired) -- 09/13/17 --, a worldwide provider of enterprise cloud applications and services for improving sales and channel performanceWill present a keynote, "Approaching Compensation and Information to Sales Ops," during .Monday, September 18 - Wednesday, September 20, 2017"Approaching Compensation and Information to Sales Ops" is scheduled for Tuesday, September 19 at 3:00 p.m. CDT.Hilton Austin 500 East 4th Street Austin, TexasCollecting data is one th ...


13.09.2017

Cardiovascular Drug Approval Rate in the U.S. Fell as Development Time Rose, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 09/12/17 -- Although the rate at which investigational drugs received marketing approval in the United States has declined in recent years, the cardiovascular approval rate trailed other drug approvals as a whole, while the time needed to develop cardiovascular drugs rose, according to a recently completed study conducted by the .Approval success rates for cardiovascular compounds fell from about 5.2% for compounds that began clinical testing during 1995-00, to ab ...


12.09.2017

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean

TORONTO, ON -- (Marketwired) -- 09/12/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has received regulatory approval for two of its exclusively licensed Women''s Health Care products for Central America and the Caribbean.After filing the regulatory documents subsequent to a signed sub-licensing agreement with Panama-based Windsor Pharmaceuticals, Easton and BMV Medica have received co ...


12.09.2017

Tetra Bio-Pharma accelerates its clinical research program in the veterinary market by entering into agreement with Dr. Louis-Philippe de Lorimier

OTTAWA, ONTARIO -- (Marketwired) -- 09/11/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced that it has added international expert Dr. Louis-Philippe de Lorimier, a board certified veterinary oncologist, to its clinical advisory board for the veterinary market."We are leveraging our current R&D work in humans to accelerate the development of the first cannabinoid-based drug for pets in the cancer-associated sup ...


11.09.2017

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

GLEN ROCK, NJ -- (Marketwired) -- 09/08/17 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of respiratory disorders, including sleep apnea, opioid-induced respiratory depression, and respiratory insufficiency due to spinal cord injury, announces that the Company''s Chief Executive Officer and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will present at the ...


08.09.2017

Tetra Bio-Pharma to Attend the 10th Annual International Partnering Conference - BioPharm America

OTTAWA, ONTARIO -- (Marketwired) -- 09/07/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug discovery, today announced that its Vice President of Business Development, Mr. Bob Bechard, is scheduled to attend the 10th Annual International Partnering Conference, BioPharm America, September 26-27 at the Sheraton Boston Hotel.BioPharm America is one of the premiere BioPartnering events providing ac ...


07.09.2017

Circassia Announces Duaklir(R) Successfully Met Primary Endpoints in AMPLIFY Phase III Study in Chronic Obstructive Pulmonary Disease

OXFORD, UNITED KINGDOM -- (Marketwired) -- 09/07/17 -- Circassia Pharmaceuticals Plc (LSE: CIR)(LSE: CIR)Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces positive top-line results from the AMPLIFY phase III study of Duaklir®* in chronic obstructive pulmonary disease (COPD), which was conducted by the Company''s partner AstraZeneca. Duaklir® is a fixed-dose comb ...


07.09.2017

PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments

Integrated offering to be provided by new dedicated service group under PAREXEL® Access BOSTON, September 6, 2017 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has launched a new end-to-end service offering to provide real-world data insights that help life science companies more effectively demonstrate product value. “In an increasingly competitive market, leveraging data to demonstrate value is critical. How ...


06.09.2017

Easton Pharmaceuticals Announces $1,000,000 cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 cdn Aggregate LOI Contract

TORONTO, ON -- (Marketwired) -- 09/05/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Closing Agreement with Canadian based 124123 Ontario Inc. (O/A - Alliance Group), Easton has advanced $1,000,000 cdn in payments to Alliance Group. Alliance executes $8,000,000 cdn aggregate LOI contract on its 90 acres of zoned industrial land.Easton Pharmaceuticals has thus far paid $1,000,000 cdn in cash out of $1.3 million cdn to Toronto bas ...


05.09.2017

Tetra Bio-Pharma Strengthens its Management Team in Preparation for the Initiation of its Commercial Activities

OTTAWA, ONTARIO -- (Marketwired) -- 08/29/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF) today announced that it has strengthened its management team in preparation for the initiation of its commercial activities with the appointments of Dr. Anne-Sophie Courtois to the position of Vice President, Marketing effective immediately and Mr. Bernard Lessard to the position of Chief Financial Officer (CFO), effective September 18, 2017. Mr. ...


29.08.2017

RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update

GLEN ROCK, NJ -- (Marketwired) -- 08/25/17 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of neurologically controlled respiratory disorders, including obstructive sleep apnea and opioid induced respiratory depression (a form of central apnea) and other respiratory and neurological conditions, has filed its June 30, 2017 Quarterly Report on Form 10-Q and is hereby providing an update ...


25.08.2017

Vitality Biopharma to Present at The MoneyShow San Francisco Conference

LOS ANGELES, CA -- (Marketwired) -- 08/23/17 -- (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to provide a presentation and participate in a cannabis industry panel session at the MoneyShow San Francisco investment conference.Company CEO Ro ...


23.08.2017

Easton Pharmaceuticals and Alliance Group Announces the Closing Of Its First Aggregate Contract Valued At $6,000,000 CDN On Its 90 Acre Portion Of Industrial Zoned Land

TORONTO, ON -- (Marketwired) -- 08/23/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Closing with Canadian based, joint venture partner, 1124123 Ontario Limited (dba / operating as - Alliance Group) -- executes $6,000,000 CDN aggregate contract on its 90 acres of industrial zoned land.The contract Alliance Group has executed is for its Aggregate business on its 90 acres of industrial zoned land, which includes recycling, manufac ...


23.08.2017

Helix Announces Peer-Review Publication of V-DOS47 in Frontiers in Immunology Journal

RICHMOND HILL, ONTARIO -- (Marketwired) -- 08/22/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the publication of a peered-reviewed V-DOS47 manuscript in "Frontiers in Immunology" journal. V-DOS47 is Helix''s second DOS47 development candidate following L-DOS47, which is currently ...


22.08.2017

Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM

MONTREAL, QUEBEC -- (Marketwired) -- 08/16/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, announced that the following individuals were elected as directors of Acasti Pharma Inc. ("Acasti" or the "Corporation") at its Annual and Special Meeting of Shareholders, held in Montreal, Canada on Aug ...


17.08.2017

Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses

TORONTO, ON -- (Marketwired) -- 08/16/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), pursuant to its previously announced closing agreement with Canadian based -- Alliance Group -- Easton has advanced $575,000 towards its acquired interest in 45 acres of a 135-acre fully owned parcel of land for the cultivation, production and sale of medical / recreational marijuana to the cannabis industry and towards other revenue producing businesses.Pursuant to the agreement, Easton Pharmaceuticals h ...


16.08.2017

Tetra Bio-Pharma Announces Approval to List on the TSX Venture Exchange

OTTAWA, ONTARIO -- (Marketwired) -- 08/16/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(CNSX: TBP)(TSX VENTURE: TBP)(OTCQB: TBPMF), today announced that its common shares have been approved for trading on the TSX Venture Exchange and that it has applied for voluntary delisting of its common shares from the Canadian Securities Exchange (CSE). Tetra''s shares will commence trading on the TSX Venture on the opening of markets on Wedne ...


16.08.2017

Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection

ATLANTA, GA and BOTHELL, WA -- (Marketwired) -- 08/15/17 -- Cocrystal Pharma, Inc. (OTCQB: COCP), a clinical stage biopharmaceutical company focused on developing innovative antiviral therapeutics, today announced the successful completion and positive data from the Phase 1a/1b study for its lead broad spectrum compound, CC-31244, in healthy volunteers and in hepatitis C virus (HCV)-infected individuals. CC-31244 is a broad-spectrum, potent NS5B non-nucleoside inhibitor (NNI) of HCV replication ...


15.08.2017

Acasti Pharma Reports First Quarter FY 2018 Financial Results

LAVAL, QUEBEC -- (Marketwired) -- 08/14/17 -- Acasti Pharma Inc. (NASDAQ: ACST)(TSX VENTURE: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced its operating and financial results for the quarter ended June 30, 2017, which is the first quarter of Acasti''s fiscal year 2018. All amounts are in Canadian dollars."We sustained our positive bu ...


14.08.2017

Fennec Provides Corporate Update and Announces Second Quarter 2017 Results

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 08/11/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX) (OTCQB: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients, today reported its corporate update and financial results for the second quarter ended June 30, 2017."As we look forward to the second half of 2017, the pending SIOPEL 6 results have the potential to mar ...


11.08.2017

Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I de C.V. For Product Launch Of AmnioSense (AL-Sense)

TORONTO, ON -- (Marketwired) -- 08/10/17 -- Easton Pharmaceuticals Inc. (OTC: EAPH) Announces execution and closing of sub-distribution agreement with Gedeon Richter Plc and its Mexican subsidiary company Gedeon Richter S.A.P.I de C.V. for the product "AmnioSense."The "AmnioSense" distribution agreement represents the second product launch with Gedeon Richter S.A.P.I. de CV following the successful launch of "Gynofit" in the second quarter of this year. An initial ...


10.08.2017

AssistRx Appoints Executive Vice President of Commerical Operations

ORLANDO, FL -- (Marketwired) -- 08/08/17 -- (ARx), the leading enterprise software platform focused on specialty and highly managed medications, today named Jason Reynolds as its executive vice president of commercial operations. In this role, Reynolds will leverage his strategic vision and process expertise to accelerate the company''s misson. The iAssist platform is focused on providing specialty pharmaceutical brands superior capabilities and insights to advance the patient journe ...


08.08.2017

New Edition of Textbook on Treating Canine Arthritis Includes Nutra Pharma Pain Remedy

CORAL SPRINGS, FL -- (Marketwired) -- 08/03/17 -- (OTCQB: NPHC), a biotechnology company marketing and in the over-the-counter (OTC) pain management market, announced today that the textbook, , includes references to Nutra Pharma''s development of cobra venom-based products for treating pain in dogs."Pet Pain-Away is a product that promises to change the way we deal with pain suffered by our companion animals," commented Rik J Deitsch, CEO of Nutra Pharma Corporation. &qu ...


03.08.2017

Rising Biosciences, Inc. Initiates Testing for FDA Approval of OTC Chronic Pain Relief Medications

NEW YORK, NY -- (Marketwired) -- 08/02/17 -- Rising India''s (OTC: RSII) ., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces that the Company has entered in the FDA testing phase on its revolutionary medical creams for chronic pain relief and neuropathic pain.These two pain creams will be the first in a series of products. Rising Biosciences, Inc. has retained an indu ...


02.08.2017

Vitality Biopharma Closes $1 Million Private Placement

LOS ANGELES, CA -- (Marketwired) -- 08/02/17 -- (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to advise that on July 28, 2017, the Company closed on a $1 million private placement.As previously described on the Company''s Current ...


02.08.2017

NSAV Announces Launch of Heartrescue.net

CRESCO, PA -- (Marketwired) -- 08/01/17 -- NSAV Holding, Inc. (OTC: NSAV) announced today the launch of an upgraded version of China''s premier cardiac emergency response website, . The launch represents yet another major milestone for world renowned Chinese medical software company, Shanghai based Vital Strategic Research Institute (VSRI). VSRI is a medical research firm with a long history of expertise in design, clinical trials and global research. VSRI has collaborated with pharma ...


01.08.2017

Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures

LAVAL, QUEBEC -- (Marketwired) -- 07/28/17 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: ACST) announces that in accordance with the terms of its outstanding convertible debentures in the total aggregate principal amount of $2,000,000 issued on February 21, 2017 (the "Debentures"), the Corporation has elected to issue an aggregate of 33,381 common shares to the holders of the Debentures in satisfaction of an aggregate of $56,980 ...


28.07.2017

Pharmacyresidency.net ranks among the best pharmacy residency services according to a recent survey

London, UK, July 26th 2017 - pharmacyresidency.net has been ranked among the best pharmacy residency services according to a recent survey. The survey that was conducted two weeks ago showed that the company was in a position of being ranked among the best because it was providing its customers with the most reliable services and within the set timeframe. The company is so happy to be ranked among the best, saying that it will continue to provide its customers with even more better services.expe ...


26.07.2017

Pharmacypersonalstatement.net welcomes feedback from customers after making some major improvements on its services

London, UK, July 26th 2017 - pharmacypersonalstatement.net has welcomed feedback from customers after making some major improvements on its services. The company which has been working very hard to meet the demands of its clients is confident that after the major improvements, its customers will get nothing short of the best. The company has said that by receiving feedbacks from its clients, it will be in a better position to know if they are contented or what they expect from the company. Onlin ...


26.07.2017

Mega Pharma expands rapidly in Latin America

LONDON, ENGLAND -- (Marketwired) -- 07/26/17 -- Over the last decade or so, the pharmaceutical industry has rapidly evolved, coinciding with huge changes to the global economy and the landscape of disease.One of the largest issues organisations now deal with is the world''s rising ageing population. Whereas medicine once dealt with acute disease, it has since moved focus, concentrating instead on chronic afflictions, such as diabetes.Regulations around drug development, however, and t ...


26.07.2017

Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman''s Diagnostics and Treatment Segment

TORONTO, ON -- (Marketwired) -- 07/24/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides shareholder update on new and existing acquisitions including its medical marijuana venture and progress on its woman''s diagnostics and treatment segment products.Easton has closed on its agreement with Alliance Group and has acquired 45 acres of agriculturally zoned land north of Toronto to cultivate, produce and facilitate the sale of its production of medical marijuana on a co-managed ...


24.07.2017

Tetra Bio-Pharma Accelerates Growth Strategy with Appointment of Bernard Fortier as CEO

OTTAWA, ONTARIO -- (Marketwired) -- 07/24/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(CNSX: TBP)(OTCQB: TBPMF) today announced that it has strengthened its management team with the appointment of Bernard Fortier to the position of Chief Executive Officer, effective today, July 24, 2017. Mr. Andre Rancourt, previous interim CEO will take the position as Chairman of the Board of Directors. Mr. Andre Audet will step down as Chairman of the Bo ...


24.07.2017

Vitality Biopharma Releases Positive Results for Treatment of Inflammatory Bowel Disease

LOS ANGELES, CA -- (Marketwired) -- 07/19/17 -- (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced positive preclinical efficacy results for its gut-targeted cannabosides in the treatment of colitis.Vitality Biopharma has developed a new class of cannabinoid prodrugs, know ...


19.07.2017

Tetra Bio-Pharma Signs Letter of Intent with Constance Therapeutics

OTTAWA, ONTARIO -- (Marketwired) -- 07/19/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(CNSX: TBP)(OTCQB: TBPMF), announced today it has signed a Letter of Intent (LOI) with Constance Therapeutics, Inc. of San Francisco, California, USA, for the clinical development and commercialization in Canada of its signature standardized, patent-pending, medicinal cannabis extract products.The AgroTek Health subsidiary of Tetra will work with Constance ...


19.07.2017

Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson''s Disease

BEVERLY HILLS, CA -- (Marketwired) -- 07/18/17 -- . (OTC PINK: RCHA), a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, today announced that it has signed a support and collaboration agreement to assist Mega Bridge. Inc., a company which is to be renamed HypGen, Inc., for $100,000 and shares of HypGen common stock."HypGen is commencing work on treatments for Parkinson''s disease. Certain of the data Rich Pharmaceuticals has am ...


18.07.2017

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Board has accepted Mr. Albert Beraldo''s resignation as director of the Company and Audit Committee Chair, effective July 14, 2017. Mr. Beraldo has conveyed to the Board that his other commitments have become ...


17.07.2017

StartCapital and Eight Dragons Company Form Contract on Corporate Development

MIAMI, FL -- (Marketwired) -- 07/14/17 -- (OTCBB: PRTT) is pleased to announce that it has been hired as a consultant to Eight Dragons Company (OTCQB: EDRG) ("Eight Dragons") to provide the following services:(a) StartCapital shall use its best efforts to provide Eight Dragons financial and business consulting services which would include evaluating various business strategies and recommending changes where appropriate and also critically evaluating Eight Dragons'' performan ...


14.07.2017

The Joint Commission Introduces Revised Pain Assessment and Management Standards, for Accredited Hospitals, to Include Use of Non-Pharmacologic Treatments and Strategies

JACKSONVILLE, FL -- (Marketwired) -- 07/13/17 -- The (NCCAOM)®, which has long advocated non-pharmacological treatments, commends The Joint Commission, an independent, not-for-profit organization that accredits nearly 21,000 health care organizations and programs in the United States, for their . The updated standards, effective January 1, 2018, will require Joint Commission accredited hospitals to provide nonpharmacological pain modalities, including acupuncture as one option, by licensed ind ...


13.07.2017

Protext Pharma CEO Discusses South Africa Cannabis License

BOCA RATON, FL -- (Marketwired) -- 07/13/17 -- Protext Pharma, Inc. (OTC PINK: TXTM) ("Protext" or "the Company"), a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated with highly bioavailable plant extracts, today provided an update with regards to its license application submitted earlier this year to the South African Government to allow the company to legally grow cannabis and produce non-psychoactive cannabinoid medicine ...


13.07.2017

Abuse-Deterrent Opioid Development and Uptake Are Tied to Efficacy and Regulatory/Payer Policies, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 07/13/17 -- Although 10 new opioid products with abuse-deterrent formulations (ADF) have received regulatory approval in the United States, lack of willingness by insurers to reimburse patients for their use is seen as a primary challenge limiting ADF uptake, according to the .According to Tufts CSDD, 96% of all opioid products prescribed in the U.S. in 2015 lacked abuse-deterrent properties, and only four of the 10 opioid products with abuse-deterrent properties ...


13.07.2017

Tetra Bio-Pharma Announces Results of Voting at Annual Shareholders'' Meeting & Provides a Corporate Update

OTTAWA, ONTARIO -- (Marketwired) -- 07/11/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(CNSX: TBP)(OTCQB: TBPMF), is pleased to announce the results of the vote at its July 10, 2017 annual shareholders'' meeting.At the meeting, some key corporate highlights which were discussed, included:About Tetra Bio-Pharma:Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE: TBP)(CSE: TBP.CN)(CNSX: TBP)(OTCQB: TBPMF) engaged in ...


11.07.2017

London Drugs'' mobile emergency response delivers supplies to BC evacuee centres and all 80 stores across Western Canada accepting donations to Red Cross for BC Wildfire Relief

RICHMOND, BRITISH COLUMBIA -- (Marketwired) -- 07/11/17 -- Today London Drugs expanded its collection of donations for the Red Cross from British Columbia and Alberta to chain-wide across Western Canada with all 80 London Drugs stores collecting donations to support in the aid of the more than 14,000 people evacuated due to the raging wildfires in British Columbia.In addition to accepting at-till donations for the Red Cross at all of its stores, London Drugs'' store managers in evacue ...


11.07.2017

Helix BioPharma Corp. Announces Collaboration with Moffitt Cancer Center

TORONTO, ONTARIO -- (Marketwired) -- 07/11/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has entered into a collaboration agreement with Moffitt Cancer Center to extract radiomics data using their proprietary HealthMyne platform from CT scans of late stage lung cancer patients treated with L-DOS47.Radiomic ...


11.07.2017

Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology

LAS VEGAS, NV -- (Marketwired) -- 07/07/17 -- Skinvisible Pharmaceuticals, Inc., (OTCQB: SKVI), is a topical and transdermal product development company with a proprietary drug delivery system Invisicare® which improves how ingredients are delivered to and through the skin including the medicinal components of marijuana; specifically CBD (cannabidiol) and the psychoactive marijuana ingredient THC (tetrahydrocannabinol). As part of the Company''s overall growth strategy in this market, ...


07.07.2017

Tetra Bio-Pharma Strengthens its Position on Bringing Marijuana to Patients in a Form Acceptable to Health Care Professionals

OTTAWA, ONTARIO -- (Marketwired) -- 07/05/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(CNSX: TBP)(OTCQB: TBPMF), today announced that it has strengthened its position on bringing marijuana to patients in the form of a prescription drug. Tetra has become a world leader in the field of cannabis drug development and its PPP001 dried cannabis drug was covered in the Global Pain Management Drugs Market analysis report published by Azoth Analytic ...


05.07.2017

Aphria Inks Major Wholesale Supply Agreement With Scientus Pharma, Health Canada Licensed Dealer

LEAMINGTON, ONTARIO -- (Marketwired) -- 07/04/17 -- Aphria Inc. ("Aphria" or the "Company") (TSX: APH)(OTCQB: APHQF), through its subsidiary Pure Natures Wellness Inc. (o/a Aphria), is pleased to announce that it entered into a major wholesale supply agreement with HydRx Farms, Ltd. (o/a Scientus Pharma) ("Scientus Pharma"). Under the terms of the Agreement, Aphria is committing to supply over 25,000 fully grown medical cannabis plants over the next 12 months to S ...


04.07.2017

A Compounding Pharmacy Near Santa Monica Is Helping Patients Using The Latest Technology

A compounding pharmacy by Santa Monica , ABC Pharmacy of Beverly Hills, is a full-service pharmacy dedicated to taking care of all of their patients’ needs. Their goal is to deliver the highest quality service and to exceed their patients’ expectations. They are driven by patient care and are highly involved with their community. This compounding pharmacy neighboring Santa Monica exudes a personal feel that big pharmaceutical companies simply cannot meet. This amazing compounding pharmacy near ...


02.07.2017

Outsourced R&D Leader Science Exchange Plans Continued Expansion, Raises $28 Million in Series C Funding

PALO ALTO, CA -- (Marketwired) -- 06/29/17 -- As further evidence of its position as the world''s leading platform for outsourced research and development (R&D), today announced it has raised $28 million in Series C funding. Founded in response to the global growth in outsourced R&D services, the company has raised more than $58 million since its inception in 2011. Norwest Venture Partners led the latest round with participation from existing investors Union Square Ventures, ...


29.06.2017

Supreme Receives Sales Approval

TORONTO, ONTARIO -- (Marketwired) -- 06/28/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (TSX VENTURE: FIRE) is pleased to announce that its wholly-owned operating subsidiary, 7ACRES, has been granted its permission to sell under the Access to Cannabis for Medical Purposes Regulations.About SupremeSupreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiar ...


28.06.2017

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 06/28/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated May 19, 2017 (the "Circular") for the Annual General and Special Meeting of Shareholders were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held in New York, New York on June 27, 2017. Detailed results of the vote for the election of di ...


28.06.2017

Mitchell Announces $70 Million First Lien Term Loan

SAN DIEGO, CA -- (Marketwired) -- 06/28/17 -- Mitchell, a leading provider of technology, connectivity and information solutions to the claims and industries, has announced the closing of a $70 million senior secured first lien term loan. The term loan is an add-on under Mitchell''s existing Credit Agreement.Mitchell expects to use the proceeds of the term loan to pay down its revolver and continue its track record of investing in technologies and companies that drive better outcome ...


28.06.2017

Tetra Bio-Pharma Expands Focus of Commercialization Activities into the Lucrative Veterinary Market

OTTAWA, ONTARIO -- (Marketwired) -- 06/28/17 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN)(CNSX: TBP)(OTCQB: TBPMF), announced today that it will also commercialize novel cannabinoid based formulations for the treatment of pet conditions.Over the last year, Tetra demonstrated its leadership in the development of human prescription cannabinoid drugs and will use the same strategy to become a leader in the field of veterinary cannabinoid drug pro ...


28.06.2017



All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 62


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Categories:


[ more PressReleases ][ RSS-Feed ]